ConductScience.org, home

Paper7755232

Fixed-dose combinations of antituberculous medications to prevent drug resistance.

Moulding T and 2 others. Ann Intern Med, 1995. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Fixed-dose combinations of antituberculous medications to prevent drug resistance. Papers, record 7755232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7755232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fixed-dose combinations of antituberculous medications to prevent drug resistance.
PubMed
Journal
Ann Intern Med
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moulding TT
2Dutt AKA K
3Reichman LBL B

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Drug Combinations
Drug Resistance, Microbial
Humans
Isoniazid
Pyrazinamide
Rifampin

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
200-93-0636PHS HHSUnited StatesPubMed
200-93-0690PHS HHSUnited StatesPubMed
K07-H103015-01PHS HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in7755233Tuberculosis: yesterday, today, and tomorrow.https://conductscience.org/library/papers/7755233

Source PubMed

Download CSV of comments and corrections

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
37507108Orthogonal Gelations to Synthesize Core-Shell Hydrogels Loaded with Nanoemulsion-Templated Drug Nanoparticles for Versatile Oral Drug Delivery.Adv Healthc Mater2023https://conductscience.org/library/papers/37507108PubMed
28959585The combined fixed-dose antituberculous drugs alter some reproductive functions with oxidative stress involvement in wistar rats.Toxicol Rep2016https://conductscience.org/library/papers/28959585PubMed
27516382Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.Clin Infect Dis2016https://conductscience.org/library/papers/27516382PubMed
26966383Patient considerations in type 2 diabetes - role of combination dapagliflozin-metformin XR.Diabetes Metab Syndr Obes2016https://conductscience.org/library/papers/26966383PubMed
26550490Single Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in Australia.AIDS Res Treat2015https://conductscience.org/library/papers/26550490PubMed
26106962Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.Clinics (Sao Paulo)2015https://conductscience.org/library/papers/26106962PubMed
24596613Tuberculosis of spine: current views in diagnosis and management.Asian Spine J2014https://conductscience.org/library/papers/24596613PubMed
22151609Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.BMC Public Health2011https://conductscience.org/library/papers/22151609PubMed
21439089Driving a decade of change: HIV/AIDS, patents and access to medicines for all.J Int AIDS Soc2011https://conductscience.org/library/papers/21439089PubMed
20500827Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.Global Health2010https://conductscience.org/library/papers/20500827PubMed
19621068Focusing on quality patient care in the new global subsidy for malaria medicines.PLoS Med2009https://conductscience.org/library/papers/19621068PubMed
12219687[Tuberculosis].Internist (Berl)2002https://conductscience.org/library/papers/12219687PubMed
8987432Multidrug-resistant tuberculosis--how far are we from New York City?West J Med1996https://conductscience.org/library/papers/8987432PubMed
8736627Tuberculosis in the elderly. Epidemiology and optimal management.Drugs Aging1996https://conductscience.org/library/papers/8736627PubMed
8725999Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8725999PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7755232

GET https://conductscience.org/api/papers/v1/7755232/authors